Form 4 for RGEN REPLIGEN CORP
Accepted 2024-12-05 00:00:00 ET · period of report 2024-12-05 · accession 0000950170-24-133812 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-05 | 2024-12-05 | RGEN | Hunt Anthony | Dir | M - OptEx | $33.87 | +11.8K | 151.6K | +8% | +$399.9K |
| D | 2024-12-05 | 2024-12-05 | RGEN | Hunt Anthony | Dir | M - OptEx | $0.00 | +11.8K | 8,856 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-05 | M | A | 11,808 | $33.87 | 151,648 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-05 | M | A | 11,808 | $0.00 | 8,856 | D | $33.87 · — to 2028-02-29 | 11,808 Common Stock | (F1) 11,808 of the shares underlying this option have vested. The remaining shares vest as follows: 2,952 shares on March 1, 2025, 2,952 shares on March 1, 2026, and 2,952 shares on March 1, 2027. |